US 10080774
Oncolytic adenovirus armed with therapeutic genes
granted A61KA61K31/513A61K35/761
Quick answer
US patent 10080774 (Oncolytic adenovirus armed with therapeutic genes) held by The Board of Regents of the University of Texas System expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/513, A61K35/761, A61K38/00, A61K38/177